Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(50.0%)
N/A
1(25.0%)
Phase 1
1(25.0%)
4Total
Phase 3(2)
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04952129Phase 1Completed

Optimal Selenium for Bowel Polyps (OSCAR)

Role: collaborator

NCT06661577Not Yet Recruiting

An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

Role: collaborator

NCT02631707Not ApplicableCompleted

The Effect of High Protein Diets on Weight Loss and Lean Muscle Mass in Patients Awaiting Bariatric Surgery

Role: collaborator

NCT00994903Phase 3Completed

Simvastatin in Colorectal Surgery

Role: collaborator

NCT00911391Phase 3Completed

Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy

Role: collaborator

NCT00441220Unknown

Cyclophosphamide in Lupus Nephritis

Role: collaborator

All 6 trials loaded